MENACTRIMS 2026
Taking place on 4–5 December 2026 in Dubai, MENACTRIMS 2027 will feature two dynamic days of plenary sessions, high-level symposia, interactive discussions, and dedicated parallel tracks for nurses.
Participants will explore the latest advances in MS treatments, therapeutic strategies, imaging, diagnosis, biomarkers, NMOSD, and related conditions.
We are honored to include the ECF Symposium in this year’s program on December 4.
The session will focus on cell-based therapies, which are rapidly reshaping the treatment landscape of multiple sclerosis by moving beyond immunomodulation toward strategies that target immune reset, remyelination, and neuroprotection. This ECF symposium brings together internationally recognized experts to review current evidence and future directions for CAR-T cell approaches, hematopoietic stem cell transplantation, and mesenchymal stem cells.
Welcome & Introduction
Prof. Hans-Peter Hartung and Prof. Bassem Yamout
CAR-T Cell Therapy in Multiple Sclerosis: Rationale and Early Clinical Evidence
Prof. Hans Peter Hartung
Autologous Haematopoietic Stem Cell Transplantation (AHSCT): Patient Selection and Long-Term Outcomes
Prof. Paolo A. Muraro
Panel Discussion & Q&A: Positioning Cell-Based Therapies in the MS Treatment Algorithm
All speakers, moderated by Prof. Hans-Peter Hartung
Discover the programme and register here.
